Latest period
$401.00M
YoY change
-1.7%
5Y CAGR
+6.4%
Peak year (2024)
$2.95B
Latest annual
$2.90B
Operating Cash Flow history chart for Zoetis (ZTS) from 2009 to 2025
Latest: $2.90B
Operating Cash Flow growth chart for Zoetis (ZTS) from 2009 to 2025
Latest: -1.7%
Operating Cash Flow history table for Zoetis (ZTS) from 2009 to 2025
| 2025 | $2.90B | -1.7% | −$49.00M | ||
| 2024 | $2.95B | +25.5% | +$600.00M | ||
| 2023 | $2.35B | +23.1% | +$441.00M | ||
| 2022 | $1.91B | -13.6% | −$301.00M | ||
| 2021 | $2.21B | +4.1% | +$87.00M | ||
| 2020 | $2.13B | +18.4% | +$331.00M | ||
| 2019 | $1.79B | +0.3% | +$5.00M | ||
| 2018 | $1.79B | +33.0% | +$444.00M | ||
| 2017 | $1.35B | +88.8% | +$633.00M | ||
| 2016 | $713.00M | +7.4% | +$49.00M | ||
| 2015 | $664.00M | +6.1% | +$38.00M | ||
| 2014 | $626.00M | -8.1% | −$55.00M | ||
| 2013 | $681.00M | +50.0% | +$227.00M | ||
| 2012 | $454.00M | -8.7% | −$43.00M | ||
| 2011 | $497.00M | +95.7% | +$243.00M | ||
| 2010 | $254.00M | +159.2% | +$156.00M | ||
| 2009 | $98.00M | — | — |
- 2025$2.90B-1.7%
- 2024$2.95B+25.5%
- 2023$2.35B+23.1%
- 2022$1.91B-13.6%
- 2021$2.21B+4.1%
- 2020$2.13B+18.4%
- 2019$1.79B+0.3%
- 2018$1.79B+33.0%
- 2017$1.35B+88.8%
- 2016$713.00M+7.4%
- 2015$664.00M+6.1%
- 2014$626.00M-8.1%
- 2013$681.00M+50.0%
- 2012$454.00M-8.7%
- 2011$497.00M+95.7%
- 2010$254.00M+159.2%
- 2009$98.00M—
Operating Cash Flow values are taken from Zoetis's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Zoetis (ZTS)
Operating Cash Flow for Zoetis (ZTS): headline value $401.00M · YoY -1.7%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Zoetis (ZTS) operating cash flow is $2.90B – edged down 1.7% year-over-year.
Across 2020–2025 (5 years), Zoetis operating cash flow produced a CAGR of +6.4% – with mixed annual results across the window.
Between 2024 and 2025, Zoetis operating cash flow edged down 1.7%, falling from $2.95B to $2.90B.
Across the available history, operating cash flow reached its high of $2.95B in 2024 and its low of $98.00M in 2009.
Zoetis Operating Cash Flow by Year
Zoetis Operating Cash Flow 2025: $2.90B
2025's operating cash flow for Zoetis came in at $2.90B, edged down 1.7% below 2024.
Zoetis Operating Cash Flow 2024: $2.95B
Zoetis posted operating cash flow of $2.95B in 2024, grew 25.5% from 2023. This figure represents the highest annual value in the available history.
Zoetis Operating Cash Flow 2023: $2.35B
In 2023, Zoetis reported operating cash flow of $2.35B, grew 23.1% from 2022.
Zoetis Operating Cash Flow 2022: $1.91B
Zoetis operating cash flow in 2022 was $1.91B, declined 13.6% below 2021.
Zoetis Operating Cash Flow 2021: $2.21B
Zoetis operating cash flow in 2021 was $2.21B.
See more financial history for Zoetis (ZTS).
Sector peers by Operating Cash Flow
Healthcare peers of Zoetis (ZTS), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation